Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Antiaging Quantum Living (AAQL) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Antiaging Quantum Living (AAQL) over the last 6 years, with Q4 2025 value amounting to 73.18%.

  • Antiaging Quantum Living's EBITDA Margin fell 59500.0% to 73.18% in Q4 2025 from the same period last year, while for Dec 2025 it was 48.79%, marking a year-over-year increase of 1005000.0%. This contributed to the annual value of 87.65% for FY2025, which is 53845900.0% up from last year.
  • Antiaging Quantum Living's EBITDA Margin amounted to 73.18% in Q4 2025, which was down 59500.0% from 16.5% recorded in Q3 2025.
  • Over the past 5 years, Antiaging Quantum Living's EBITDA Margin peaked at 16.5% during Q3 2025, and registered a low of 2477.25% during Q2 2023.
  • For the 5-year period, Antiaging Quantum Living's EBITDA Margin averaged around 543.42%, with its median value being 169.3% (2022).
  • As far as peak fluctuations go, Antiaging Quantum Living's EBITDA Margin skyrocketed by 48132500bps in 2021, and later tumbled by -15978800bps in 2023.
  • Quarter analysis of 5 years shows Antiaging Quantum Living's EBITDA Margin stood at 1379.29% in 2021, then skyrocketed by 88bps to 169.3% in 2022, then crashed by -817bps to 1553.09% in 2023, then surged by 96bps to 67.23% in 2024, then fell by -9bps to 73.18% in 2025.
  • Its last three reported values are 73.18% in Q4 2025, 16.5% for Q3 2025, and 48.49% during Q2 2025.